130 related articles for article (PubMed ID: 29749649)
1. Transgelin-2 in immunity: Its implication in cell therapy.
Jo S; Kim HR; Mun Y; Jun CD
J Leukoc Biol; 2018 Nov; 104(5):903-910. PubMed ID: 29749649
[TBL] [Abstract][Full Text] [Related]
2. Transgelin-2 in B-Cells Controls T-Cell Activation by Stabilizing T Cell - B Cell Conjugates.
Na BR; Kwon MS; Chae MW; Kim HR; Kim CH; Jun CD; Park ZY
PLoS One; 2016; 11(5):e0156429. PubMed ID: 27232882
[TBL] [Abstract][Full Text] [Related]
3. Cell-permeable transgelin-2 as a potent therapeutic for dendritic cell-based cancer immunotherapy.
Kim HR; Park JS; Park JH; Yasmin F; Kim CH; Oh SK; Chung IJ; Jun CD
J Hematol Oncol; 2021 Mar; 14(1):43. PubMed ID: 33731208
[TBL] [Abstract][Full Text] [Related]
4. Transgelin-2: A Double-Edged Sword in Immunity and Cancer Metastasis.
Kim HR; Park JS; Karabulut H; Yasmin F; Jun CD
Front Cell Dev Biol; 2021; 9():606149. PubMed ID: 33898417
[TBL] [Abstract][Full Text] [Related]
5. TAGLN2-mediated actin stabilization at the immunological synapse: implication for cytotoxic T cell control of target cells.
Na BR; Jun CD
BMB Rep; 2015 Jul; 48(7):369-70. PubMed ID: 26129675
[TBL] [Abstract][Full Text] [Related]
6. B-1 cells express transgelin 2: unexpected lymphocyte expression of a smooth muscle protein identified by proteomic analysis of peritoneal B-1 cells.
Francés R; Tumang JR; Kaku H; Gurdak SM; Rothstein TL
Mol Immunol; 2006 May; 43(13):2124-9. PubMed ID: 16487589
[TBL] [Abstract][Full Text] [Related]
7. Transgelin-2: Biochemical and Clinical Implications in Cancer and Asthma.
Yin LM; Ulloa L; Yang YQ
Trends Biochem Sci; 2019 Oct; 44(10):885-896. PubMed ID: 31256982
[TBL] [Abstract][Full Text] [Related]
8. L-plastin regulates the stability of the immune synapse of naive and effector T-cells.
Wabnitz G; Balta E; Samstag Y
Adv Biol Regul; 2017 Jan; 63():107-114. PubMed ID: 27720134
[TBL] [Abstract][Full Text] [Related]
9. AKT and JNK Signaling Pathways Increase the Metastatic Potential of Colorectal Cancer Cells by Altering Transgelin Expression.
Zhou H; Zhang Y; Chen Q; Lin Y
Dig Dis Sci; 2016 Apr; 61(4):1091-7. PubMed ID: 26694173
[TBL] [Abstract][Full Text] [Related]
10. TAGLN2 regulates T cell activation by stabilizing the actin cytoskeleton at the immunological synapse.
Na BR; Kim HR; Piragyte I; Oh HM; Kwon MS; Akber U; Lee HS; Park DS; Song WK; Park ZY; Im SH; Rho MC; Hyun YM; Kim M; Jun CD
J Cell Biol; 2015 Apr; 209(1):143-62. PubMed ID: 25869671
[TBL] [Abstract][Full Text] [Related]
11. Transgelin: an actin-binding protein and tumour suppressor.
Assinder SJ; Stanton JA; Prasad PD
Int J Biochem Cell Biol; 2009 Mar; 41(3):482-6. PubMed ID: 18378184
[TBL] [Abstract][Full Text] [Related]
12. Transgelin mediates transforming growth factor-β1-induced proliferation of human periodontal ligament cells.
Mitarai H; Wada N; Hasegawa D; Yoshida S; Sonoda M; Tomokiyo A; Hamano S; Serita S; Mizumachi H; Maeda H
J Periodontal Res; 2017 Dec; 52(6):984-993. PubMed ID: 28590058
[TBL] [Abstract][Full Text] [Related]
13. Expression of the actin-associated protein transgelin (SM22) is decreased in prostate cancer.
Prasad PD; Stanton JA; Assinder SJ
Cell Tissue Res; 2010 Feb; 339(2):337-47. PubMed ID: 20012321
[TBL] [Abstract][Full Text] [Related]
14. Transgelin-2: A potential oncogenic factor.
Meng T; Liu L; Hao R; Chen S; Dong Y
Tumour Biol; 2017 Jun; 39(6):1010428317702650. PubMed ID: 28639888
[TBL] [Abstract][Full Text] [Related]
15. Mutations affecting the actin regulator WD repeat-containing protein 1 lead to aberrant lymphoid immunity.
Pfajfer L; Mair NK; Jiménez-Heredia R; Genel F; Gulez N; Ardeniz Ö; Hoeger B; Bal SK; Madritsch C; Kalinichenko A; Chandra Ardy R; Gerçeker B; Rey-Barroso J; Ijspeert H; Tangye SG; Simonitsch-Klupp I; Huppa JB; van der Burg M; Dupré L; Boztug K
J Allergy Clin Immunol; 2018 Nov; 142(5):1589-1604.e11. PubMed ID: 29751004
[TBL] [Abstract][Full Text] [Related]
16. Transgelins, cytoskeletal proteins implicated in different aspects of cancer development.
Dvorakova M; Nenutil R; Bouchal P
Expert Rev Proteomics; 2014 Apr; 11(2):149-65. PubMed ID: 24476357
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of transgelin blocks interleukin-8 utilization and suppresses vasculogenic mimicry in breast cancer cells.
Aikins AR; Kim M; Raymundo B; Kim CW
Exp Biol Med (Maywood); 2017 Mar; 242(6):573-583. PubMed ID: 28058861
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of Transgelin-2 in Tumorigenesis.
Zeng C; Zhang H
Discov Med; 2021; 32(165):23-28. PubMed ID: 35219353
[TBL] [Abstract][Full Text] [Related]
19. Purification and properties of transgelin: a transformation and shape change sensitive actin-gelling protein.
Shapland C; Hsuan JJ; Totty NF; Lawson D
J Cell Biol; 1993 Jun; 121(5):1065-73. PubMed ID: 8501116
[TBL] [Abstract][Full Text] [Related]
20. Actin stabilizer TAGLN2 potentiates adoptive T cell therapy by boosting the inside-out costimulation via lymphocyte function-associated antigen-1.
Jeon BN; Kim HR; Chung YS; Na BR; Park H; Hong C; Fatima Y; Oh H; Kim CH; Jun CD
Oncoimmunology; 2018; 7(12):e1500674. PubMed ID: 30524895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
